National Cancer Institute Amended; Notice of Meeting, 15782 [2012-6352]
Download as PDF
<![CDATA[
15782
Federal Register / Vol. 77, No. 52 / Friday, March 16, 2012 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN SUMMARY, CHILD HEALTH DISPARITIES SUBSTUDY
Estimated
number of
respondents
Type of
respondent
Data collection activity
Estimated
number of
responses per
respondent
Average
burden hours
per response
Estimated
total annual
burden hours
Pregnant Women/
Mothers of children
ages 0–5.
Members of NCS target population (not
NCS participants).
1,260
1
0.08
105
Cognitive Interview .......
Mothers of children
ages 0–5.
Members of NCS target population (not
NCS participants).
60
1
1.33
80
Primary Data Collection
Pregnant Women/
Mothers of children
ages 0–5.
Mothers of children
ages 0–5.
Members of NCS target population (not
NCS participants).
600
600
2
1
1.08
1.08
1,300
650
Saliva Collection ...........
Pregnant Women/
Mothers of children
ages 0–5.
Additional mothers of
children ages 0–5.
Children ages 0–5 .......
Members of NCS target population (not
NCS participants).
260
260
520
2
1
1
0.25
0.25
0.25
130
65
130
Total ......................
mstockstill on DSK4VPTVN1PROD with NOTICES
Consent ........................
.....................................
.....................................
1,780
........................
........................
2,460
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to minimize
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Dr. Sarah L.
Glavin, Deputy Director, Office of
Science Policy, Analysis and
Communication, National Institute of
Child Health and Human Development,
31 Center Drive, Room 2A18, Bethesda,
Maryland 20892, or call non-toll free
number (301) 496–1877 or email your
request, including your address to
glavins@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
VerDate Mar<15>2010
17:10 Mar 15, 2012
Jkt 226001
Dated: March 12, 2012.
Sarah L. Glavin,
Deputy Director, Office of Science Policy,
Analysis and Communications, National
Institute of Child Health and Human
Development.
[FR Doc. 2012–6354 Filed 3–15–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, April
18, 2012, 1 p.m. to April 18, 2012, 5
p.m., National Institutes of Health, 6116
Executive Boulevard, 8055B, Rockville,
MD 20852 which was published in the
Federal Register on March 1, 2012, 77
FR 12600.
This notice is being amended to
change the times of the meeting from 1
p.m.–5 p.m. to 12 p.m.–3 p.m. The
meeting is closed to the public.
Dated: March 9, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–6352 Filed 3–15–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 77, Number 52 (Friday, March 16, 2012)]
[Notices]
[Page 15782]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6352]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, April 18, 2012, 1 p.m. to
April 18, 2012, 5 p.m., National Institutes of Health, 6116 Executive
Boulevard, 8055B, Rockville, MD 20852 which was published in the
Federal Register on March 1, 2012, 77 FR 12600.
This notice is being amended to change the times of the meeting
from 1 p.m.-5 p.m. to 12 p.m.-3 p.m. The meeting is closed to the
public.
Dated: March 9, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-6352 Filed 3-15-12; 8:45 am]
BILLING CODE 4140-01-P
